Evolving With Our Customers - A $100 Million Expansion

Vaccine Vials GettyImages-1316775813

Innovative therapeutics and drug delivery systems capable of delivering more effective, patient-centric treatment plans are shifting the manufacturing needs of many pharmaceutical and biotech companies. To meet this shifting demand, manufacturing partners must also evolve to meet customer needs and deliver safe, high-quality products to patient populations.

Baxter BioPharma Solutions’ approximately $100 million expansion of its sterile fill/finish manufacturing facility in Halle/Westfalen, Germany adds state-of-the-art equipment for the filling of vials and pre-filled syringes to help meet the growing demand for biologics and self-administered doses. Both manufacturing lines will be set up to offer a wide range of flexibility to meet the customers' demands from both a capability and capacity standpoint. Discover the potential for innovative solutions in this recent expansion.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online